Cargando…

Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis

OBJECTIVES: To investigate the influence of early disease-modifying antirheumatic drug (DMARD) treatment on long-term functional outcome in patients with recent-onset inflammatory polyarthritis (IP), and the impact of the duration of first and subsequent DMARD treatment. METHODS: 642 subjects from a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farragher, Tracey M, Lunt, Mark, Fu, Bo, Bunn, Diane, Symmons, Deborah P M
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2009
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927614/ https://www.ncbi.nlm.nih.gov/pubmed/19858538 http://dx.doi.org/10.1136/ard.2009.108639

Ejemplares similares

Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis
por: Franklin, Jarrod, et al.
Publicado: (2010)

In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register
por: Verstappen, Suzanne M M, et al.
Publicado: (2011)

Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies
por: Farragher, Tracey M, et al.
Publicado: (2010)

The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Camacho, E M, et al.
Publicado: (2010)

The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis
por: Naz, Sophia M, et al.
Publicado: (2008)

Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study
por: Mirjafari, Hoda, et al.
Publicado: (2011)

Association of Functional Outcome With Both Personal- and Area-Level Socioeconomic Inequalities in Patients With Inflammatory Polyarthritis
por: Harrison, Mark J, et al.
Publicado: (2009)

Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?
por: Hider, S L, et al.
Publicado: (2009)

Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients
por: Farragher, Tracey M, et al.
Publicado: (2010)

The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Plant, Darren, et al.
Publicado: (2011)

Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Scirè, Carlo A, et al.
Publicado: (2014)

N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR)
por: Mirjafari, Hoda, et al.
Publicado: (2014)

Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register—the EPIC-2-NOAR Study)
por: Lahiri, Manjari, et al.
Publicado: (2014)

Reduction of Long-Term Disability in Inflammatory Polyarthritis by Early and Persistent Suppression of Joint Inflammation: Results From the Norfolk Arthritis Register
por: Scirè, Carlo A, et al.
Publicado: (2011)

Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population
por: Verstappen, Suzanne M M, et al.
Publicado: (2013)

Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis
por: Farragher, Tracey M, et al.
Publicado: (2008)

Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register
por: Camacho, E M, et al.
Publicado: (2011)

Association of Morbid Obesity With Disability in Early Inflammatory Polyarthritis: Results From the Norfolk Arthritis Register
por: Humphreys, J H, et al.
Publicado: (2013)

Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis
por: Viatte, Sebastien, et al.
Publicado: (2016)

Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients
por: Goodson, N J, et al.
Publicado: (2008)

Influence of Inflammatory Polyarthritis on Quantitative Heel Ultrasound Measurements
por: Pye, Stephen R, et al.
Publicado: (2012)

Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
por: Burr, Marian L, et al.
Publicado: (2012)

Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Cook, Michael J., et al.
Publicado: (2016)

Learned helplessness predicts functional disability, pain and fatigue in patients with recent-onset inflammatory polyarthritis
por: Camacho, Elizabeth M., et al.
Publicado: (2013)

The performance of anti–cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: Results from the Norfolk Arthritis Register
por: Bukhari, M, et al.
Publicado: (2007)

Association between socioeconomic status, learned helplessness, and disease outcome in patients with inflammatory polyarthritis
por: Camacho, E M, et al.
Publicado: (2012)

HLA–DRB1 Amino Acid Positions 11/13, 71, and 74 Are Associated With Inflammation Level, Disease Activity, and the Health Assessment Questionnaire Score in Patients With Inflammatory Polyarthritis
por: Ling, Stephanie F., et al.
Publicado: (2016)

Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register
por: Humphreys, Jennifer H, et al.
Publicado: (2016)

Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification
por: Lunt, Mark, et al.
Publicado: (2009)

Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study
por: Bluett, James, et al.
Publicado: (2018)

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study
por: Combe, Bernard, et al.
Publicado: (2014)

Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
por: Charles-Schoeman, Christina, et al.
Publicado: (2016)

Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register
por: Gwinnutt, James M, et al.
Publicado: (2018)

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register
por: Lord, Paul A. C., et al.
Publicado: (2010)

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
por: Jani, Meghna, et al.
Publicado: (2017)

Clopidogrel-Associated Migratory Inflammatory Polyarthritis
por: Ayesha, Bibi, et al.
Publicado: (2019)

Antirheumatic treatment, disease activity and risk of Staphylococcus aureus bacteraemia in rheumatoid arthritis: a nationwide nested case–control study
por: Dieperink, Sabine Sparre, et al.
Publicado: (2022)

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study
por: Gabay, Cem, et al.
Publicado: (2016)

Paediatric hospitalisation related to medications administration errors of non-opioid analgesics, antipyretics and antirheumatics in England and Wales: a longitudinal ecological study
por: Naser, Abdallah Y, et al.
Publicado: (2023)

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
por: Soliman, Moetaza M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bucliuk04t0ec3p0dt48bbobma